It is well established that certain NSAIDs have beneficial effects in the chemoprevention of colorectal cancer due to their inhibition activity against cyclooxygenase-2 (COX-2) isoform, which is overexpressed in this tumor disease. This evidence concerns the gene PTGS2 and colorectal cancer.